RGT
Click for more information
2.90% 35.5¢ argent biopharma limited

Ann: Major Regulatory Milestones Achieved for Pharma Business, page-51

  1. the Zig
    1,031 Posts.
    lightbulb Created with Sketch. 104
    clock Created with Sketch.
    24/01/19
    11:56
    Post #: 37210519
    good luck 28four.
    then we better hold on. lost all faith in this stock but still have hope of a recovery.

    fingers crossed.
    the Zig..
    MXC Price at posting: 4.1¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS New drilling at the Rogozna Project delivers a standout intercept, highlighting significant resource expansion potential
right-arrow Created with Sketch.
RDN Preliminary interpretation of Andover South reveals key NE-trending corridor hosting lithium mineralization
right-arrow Created with Sketch.
NEWS $140,000 in grant funding has been secured for drilling at Golden Ridge, with preparations underway for two exciting prospects
right-arrow Created with Sketch.
NEWS Uncover the potential at the Storm Project, where exceptional RC drill results reveal 22.9m at 8.5% Cu, indicating significant resource expansion beyond the Cyclone Deposit
right-arrow Created with Sketch.
NEWS Discover how gas production wells are progressing with successful drilling and promising early gas flows
right-arrow Created with Sketch.
NEWS High-grade manganese found at the W2 prospect in Wandanya
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
35.5¢ 		Change
0.010(2.90%) 		Mkt cap ! $17.18M
Open High Low Value Volume
35.0¢ 36.0¢ 34.5¢ $6.75K 18.84K

Buyers (Bids)

No. Vol. Price($)
1 1885 29.0¢
 

Sellers (Offers)

Price($) Vol. No.
36.5¢ 100 1
View Market Depth
Last trade - 13.02pm 27/09/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.